Impact of hydrocortisone replacement on bone mineral density and bone turnover markers in patients with primary adrenal insufficiency

Impact of hydrocortisone replacement on bone mineral density and bone turnover markers in patients with primary adrenal insufficiency

Objective. The study was aimed to assess the effect of hydrocortisone (HC) replacement therapy on bone mineral density (BMD) and bone turnover markers in patients with primary adrenal insufficiency (PAI).

Bibliographic Details
Main Authors: Yazidi Meriem, Danguir Cyrine, Maamer Dhouha, Oueslati Ibtissem, Khiari Karima, Elleuch Mohamed, Feki Moncef, Chihaoui Melika
Format: Article
Language:English
Published: Sciendo 2022-07-01
Series:Endocrine Regulations
Subjects:
primary adrenal insufficiency
bone mineral density
bone turnover markers
hydro-cortisone
osteoporosis
Online Access:https://doi.org/10.2478/enr-2022-0022

Internet

https://doi.org/10.2478/enr-2022-0022

Similar Items